Literature DB >> 8092902

Radical lymph node dissection for cancer of the thoracic esophagus.

H Akiyama1, M Tsurumaru, H Udagawa, Y Kajiyama.   

Abstract

OBJECTIVE: The authors documented the localization and frequency of lymphatic spread in squamous cell carcinoma of the thoracic esophagus and evaluated the influence of radical systematic lymph node dissection on patient survival. SUMMARY BACKGROUND DATA: From accumulated surgical experience, it was suggested that some of the patients with lymph nodal involvement from cancer could be cured by its clearance. However, it is only recently that cancer of the esophagus has been evaluated in terms of analyzing lymphatic spread and results of lymphadenectomy.
METHODS: Among 1298 patients admitted to the Toranomon Hospital between 1973 and 1993, 913 (70.3%) had resections, including curative and palliative procedures. For this study, 717 patients with TNM RO (resection with no residual tumor at operation in TNM classification) were analyzed. Survival was compared between groups of patients with less extensive thoracoabdominal (two-field) dissections and extensive collothoracoabdominal (three-field) dissections.
RESULTS: Comparative study revealed that 5-year survival rate for TNM RO patients after free-field dissection (55.0%) was significantly better (log rank test, p = 0.0013) than the rate after two-field dissection (38.3%). The results were particularly significant in subgroups with stage III and IV (because of nodal factor). Overall 5-year survival rate after all resections was 42.4%.
CONCLUSIONS: The role of radical lymph node dissection in cancer of the thoracic esophagus evaluated. Long-term survival was compared between two groups with two- and three-field dissection. It was concluded that survival rate was significantly better in patients with extensive three-field dissection.

Entities:  

Mesh:

Year:  1994        PMID: 8092902      PMCID: PMC1234394          DOI: 10.1097/00000658-199409000-00012

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  8 in total

1.  THE SURGICAL TREATMENT OF CARCINOMA OF THE ESOPHAGUS AND CARDIA.

Authors:  A LOGAN
Journal:  J Thorac Cardiovasc Surg       Date:  1963-08       Impact factor: 5.209

2.  Experiences of about 3,000 cases with cancer of the oesophagus and the cardia.

Authors:  K NAKAYAMA; K HIROTA
Journal:  Aust N Z J Surg       Date:  1962-02

3.  Selective therapeutic approach to cancer of the lower esophagus and cardia.

Authors:  T R DeMeester; G Zaninotto; K E Johansson
Journal:  J Thorac Cardiovasc Surg       Date:  1988-01       Impact factor: 5.209

4.  Transhiatal esophagectomy without thoracotomy for carcinoma of the thoracic esophagus.

Authors:  M B Orringer
Journal:  Ann Surg       Date:  1984-09       Impact factor: 12.969

5.  Inefficacy of internal mammary nodes dissection in breast cancer surgery.

Authors:  U Veronesi; P Valagussa
Journal:  Cancer       Date:  1981-01-01       Impact factor: 6.860

6.  En bloc resection for neoplasms of the esophagus and cardia.

Authors:  D B Skinner
Journal:  J Thorac Cardiovasc Surg       Date:  1983-01       Impact factor: 5.209

7.  Principles of surgical treatment for carcinoma of the esophagus: analysis of lymph node involvement.

Authors:  H Akiyama; M Tsurumaru; T Kawamura; Y Ono
Journal:  Ann Surg       Date:  1981-10       Impact factor: 12.969

8.  Factors influencing morbidity and mortality in esophageal carcinoma.

Authors:  G B Ong; K H Lam; J Wong; T K Lim
Journal:  J Thorac Cardiovasc Surg       Date:  1978-12       Impact factor: 5.209

  8 in total
  208 in total

1.  Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years.

Authors:  N Ando; S Ozawa; Y Kitagawa; Y Shinozawa; M Kitajima
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

2.  Guidelines for the management of oesophageal and gastric cancer.

Authors:  W H Allum; S M Griffin; A Watson; D Colin-Jones
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

3.  Does fibrin glue reduce lymph leakage (pleural effusion) after extended esophagectomy? Prospective randomized clinical trial.

Authors:  Mitsuo Tachibana; Shoichi Kinugasa; Hiroshi Yoshimura; Dipok Kumar Dhar; Shuhei Ueda; Toshiyuki Fujii; Hitoshi Kohno; Naofumi Nagasue
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

4.  Mediastinoscopy-assisted esophagectomy for esophageal cancer in patients with serious comorbidities.

Authors:  Naohiko Koide; Daisuke Takeuchi; Akira Suzuki; Shinichi Miyagawa
Journal:  Surg Today       Date:  2011-11-10       Impact factor: 2.549

5.  Comparison of the short-term health-related quality of life in patients with esophageal cancer with different routes of gastric tube reconstruction after minimally invasive esophagectomy.

Authors:  Hao Wang; Lijie Tan; Mingxiang Feng; Yi Zhang; Qun Wang
Journal:  Qual Life Res       Date:  2010-09-21       Impact factor: 4.147

6.  Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma.

Authors:  T Lerut; P Nafteux; J Moons; W Coosemans; G Decker; P De Leyn; D Van Raemdonck; N Ectors
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

7.  Diagnostic accuracy of ¹⁸F-FDG PET/CT for detection of suspected recurrence in patients with oesophageal carcinoma.

Authors:  Punit Sharma; Sachin Jain; Sellam Karunanithi; Sujoy Pal; Pramod Kumar Julka; Sanjay Thulkar; Arun Malhotra; Chandrasekhar Bal; Rakesh Kumar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-01-17       Impact factor: 9.236

8.  Association of the primary tumor location with the site of tumor recurrence after curative resection of thoracic esophageal carcinoma.

Authors:  Yuichiro Doki; Osamu Ishikawa; Ko Takachi; Isao Miyashiro; Yo Sasaki; Hiroaki Ohigashi; Kohei Murata; Terumasa Yamada; Shingo Noura; Hidetoshi Eguchi; Toshiyuki Kabuto; Shingi Imaoka
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

9.  Characteristics of recurrence after radical esophagectomy with two-field lymph node dissection for thoracic esophageal cancer.

Authors:  Cheng-Lin Li; Fu-Li Zhang; Ya-DI Wang; Chun Han; Guo-Gui Sun; Qing Liu; Yun-Jie Cheng; Shao-Wu Jing; Cong-Rong Yang
Journal:  Oncol Lett       Date:  2012-10-01       Impact factor: 2.967

10.  Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus.

Authors:  Nasser Altorki; Michael Kent; Cathy Ferrara; Jeffrey Port
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.